Literature DB >> 31273496

Cerebellar mutism syndrome: current approaches to minimize risk for CMS.

Kelsey Cobourn1,2, Fares Marayati1,3, Deki Tsering1, Owen Ayers1,3, John S Myseros1,4, Suresh N Magge1,4, Chima O Oluigbo1,4, Robert F Keating5,6.   

Abstract

PURPOSE: Cerebellar mutism syndrome (CMS) is a serious source of morbidity following posterior fossa surgery in the pediatric population. However, methods for effectively decreasing its incidence and impact remain unclear. It is our aim to examine the impact of adjusting surgical factors, namely the use of a telovelar approach and avoidance of cavitronic ultrasonic aspirator, on the incidence of CMS in our population as well as outlining potential pre-, intra-, and postoperative factors that may contribute to its development.
METHODS: Retrospective review was performed to identify patients undergoing posterior fossa surgery for resection of a medulloblastoma. Demographic, surgical, and postoperative data were collected. These data were analyzed for possible correlations to the risk of developing CMS via univariate analysis. For factors found to be significant, a multivariate analysis was performed to assess their independence.
RESULTS: Seven of 65 patients (10.8%) developed CMS postoperatively. Factors found to be significantly associated with a higher risk of CMS were the degree of retraction utilized during the procedure (p = 0.0000) and incision of the vermis (p = 0.0294). Although they did not reach the threshold of statistical significance, tumor vascularity (p = 0.19), adoption of a transvermian approach (p = 0.19), and lack of intraoperative imaging (p = 0.17) exhibited strongly suggestive trends towards a correlation with CMS. DISCUSSION: In an effort to reduce the incidence and severity of CMS in our population, our institution adopted surgical practices that minimize tissue trauma and mitigate postoperative edema. This included the use of a telovelar over a transvermian approach to obviate the need for vermian incision, avoidance of the CUSA, and minimization of heavy retraction during surgery. This was successful in reducing the incidence of CMS from 39% in our medulloblastoma patients to 10.8%. The development of CMS after posterior fossa surgery appears to be a "two-hit" phenomenon requiring a combination of existing predisposition, surgical injury, and postoperative exacerbation. Therefore, it is critical to identify the factors involved at each stage and investigate treatments to target them appropriately.

Entities:  

Keywords:  Cerebellar mutism; Posterior fossa syndrome; Transient cerebellar mutism

Mesh:

Year:  2019        PMID: 31273496     DOI: 10.1007/s00381-019-04240-x

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  5 in total

1.  Conversations on mutism: risk stratification for cerebellar mutism based on medulloblastoma subtype.

Authors:  Jeffrey B Russ; William A Weiss
Journal:  Neuro Oncol       Date:  2020-02-20       Impact factor: 12.300

2.  Cerebellar mutism syndrome in pediatric head trauma with cerebellar injury.

Authors:  Anaïs Chivet; Isabelle Delestret; Céline Brodar; Matthieu Vinchon
Journal:  Childs Nerv Syst       Date:  2022-01-07       Impact factor: 1.475

3.  Postoperative speech impairment and cranial nerve deficits after secondary surgery of posterior fossa tumours in childhood: a prospective European multicentre study.

Authors:  J Kjær Grønbæk; S Toescu; R Frič; P Nilsson; C Castor; C Mallucci; B Pizer; K Aquilina; E Molinari; M Aasved Hjort; A Karppinen; G Rutkauskiene; K Mudra; B Markia; K van Baarsen; E Hoving; J Zipfel; M Wibroe; K Nysom; K Schmiegelow; A Sehested; R Mathiasen; M Juhler
Journal:  Childs Nerv Syst       Date:  2022-02-14       Impact factor: 1.475

4.  Posterior fossa syndrome in a population of children and young adults with medulloblastoma: a retrospective, multicenter Italian study on incidence and pathophysiology in a histologically homogeneous and consecutive series of 136 patients.

Authors:  Camilla de Laurentis; Paola M F Cristaldi; Paola Rebora; Maria Grazia Valsecchi; Veronica Biassoni; Elisabetta Schiavello; Giorgio G Carrabba; Andrea Trezza; Francesco DiMeco; Paolo Ferroli; Giuseppe Cinalli; Marco Locatelli; Marco Cenzato; Giuseppe Talamonti; Marco M Fontanella; Giannatonio Spena; Roberto Stefini; Claudio Bernucci; Silvio Bellocchi; Davide Locatelli; Maura Massimino; Carlo Giussani
Journal:  J Neurooncol       Date:  2022-06-29       Impact factor: 4.506

5.  The Clinical and Prognostic Impact of the Choice of Surgical Approach to Fourth Ventricular Tumors in a Single-Center, Single-Surgeon Cohort of 92 Consecutive Pediatric Patients.

Authors:  Nicola Onorini; Pietro Spennato; Valentina Orlando; Fabio Savoia; Camilla Calì; Carmela Russo; Lucia De Martino; Maria Serena de Santi; Giuseppe Mirone; Claudio Ruggiero; Lucia Quaglietta; Giuseppe Cinalli
Journal:  Front Oncol       Date:  2022-02-24       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.